Limitations in discerning the effects of risperidone and its 9-hydroxy metabolite on prolactin levels in a small study of patients with schizophrenia.
Pandina
Gahan J
GJ
Canuso
Carla M
CM
Youssef
Eriene
E
Kujawa
Mary
M
Mahmoud
Ramy
R
D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000493:pharmacokinetics* / Q000627:therapeutic use; D006801:Humans; D007555:Isoxazoles / Q000378:metabolism; D000068882:Paliperidone Palmitate; D011388:Prolactin / Q000097:blood*; D011743:Pyrimidines / Q000378:metabolism; D018967:Risperidone / Q000009:adverse effects* / Q000493:pharmacokinetics* / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy / Q000378:metabolism*
D014150:Antipsychotic Agents; D007555:Isoxazoles; D011743:Pyrimidines; D011388:Prolactin; D018967:Risperidone; D000068882:Paliperidone Palmitate